Cargando…

New mechanisms and biomarkers of lymph node metastasis in cervical cancer: reflections from plasma proteomics

OBJECTIVE: Lymph node metastasis (LNM) and lymphatic vasculature space infiltration (LVSI) in cervical cancer patients indicate a poor prognosis, but satisfactory methods for diagnosing these phenotypes are lacking. This study aimed to find new effective plasma biomarkers of LNM and LVSI as well as...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Sai, Liu, Xiaoli, Ju, Shuang, Mu, Wendi, Abulikemu, Gulijinaiti, Zhen, Qianwei, Yang, Jiaqi, Zhang, Jingjing, Li, Yi, Liu, Hongli, Chen, Qian, Cui, Baoxia, Wu, Shuxia, Zhang, Youzhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10492398/
https://www.ncbi.nlm.nih.gov/pubmed/37689639
http://dx.doi.org/10.1186/s12014-023-09427-8
_version_ 1785104248032198656
author Han, Sai
Liu, Xiaoli
Ju, Shuang
Mu, Wendi
Abulikemu, Gulijinaiti
Zhen, Qianwei
Yang, Jiaqi
Zhang, Jingjing
Li, Yi
Liu, Hongli
Chen, Qian
Cui, Baoxia
Wu, Shuxia
Zhang, Youzhong
author_facet Han, Sai
Liu, Xiaoli
Ju, Shuang
Mu, Wendi
Abulikemu, Gulijinaiti
Zhen, Qianwei
Yang, Jiaqi
Zhang, Jingjing
Li, Yi
Liu, Hongli
Chen, Qian
Cui, Baoxia
Wu, Shuxia
Zhang, Youzhong
author_sort Han, Sai
collection PubMed
description OBJECTIVE: Lymph node metastasis (LNM) and lymphatic vasculature space infiltration (LVSI) in cervical cancer patients indicate a poor prognosis, but satisfactory methods for diagnosing these phenotypes are lacking. This study aimed to find new effective plasma biomarkers of LNM and LVSI as well as possible mechanisms underlying LNM and LVSI through data-independent acquisition (DIA) proteome sequencing. METHODS: A total of 20 cervical cancer plasma samples, including 7 LNM-/LVSI-(NC), 4 LNM-/LVSI + (LVSI) and 9 LNM + /LVSI + (LNM) samples from a cohort, were subjected to DIA to identify differentially expressed proteins (DEPs) for LVSI and LNM. Subsequently, Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were performed for DEP functional annotation. Protein–protein interaction (PPI) and weighted gene coexpression network analysis (WGCNA) were used to detect new effective plasma biomarkers and possible mechanisms. RESULTS: A total of 79 DEPs were identified in the cohort. GO and KEGG analyses showed that DEPs were mainly enriched in the complement and coagulation pathway, lipid and atherosclerosis pathway, HIF-1 signal transduction pathway and phagosome and autophagy. WGCNA showed that the enrichment of the green module differed greatly between groups. Six interesting core DEPs (SPARC, HPX, VCAM1, TFRC, ERN1 and APMAP) were confirmed to be potential plasma diagnostic markers for LVSI and LNM in cervical cancer patients. CONCLUSION: Proteomic signatures developed in this study reflected the potential plasma diagnostic markers and new possible pathogenesis mechanisms in the LVSI and LNM of cervical cancer. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12014-023-09427-8.
format Online
Article
Text
id pubmed-10492398
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-104923982023-09-10 New mechanisms and biomarkers of lymph node metastasis in cervical cancer: reflections from plasma proteomics Han, Sai Liu, Xiaoli Ju, Shuang Mu, Wendi Abulikemu, Gulijinaiti Zhen, Qianwei Yang, Jiaqi Zhang, Jingjing Li, Yi Liu, Hongli Chen, Qian Cui, Baoxia Wu, Shuxia Zhang, Youzhong Clin Proteomics Research OBJECTIVE: Lymph node metastasis (LNM) and lymphatic vasculature space infiltration (LVSI) in cervical cancer patients indicate a poor prognosis, but satisfactory methods for diagnosing these phenotypes are lacking. This study aimed to find new effective plasma biomarkers of LNM and LVSI as well as possible mechanisms underlying LNM and LVSI through data-independent acquisition (DIA) proteome sequencing. METHODS: A total of 20 cervical cancer plasma samples, including 7 LNM-/LVSI-(NC), 4 LNM-/LVSI + (LVSI) and 9 LNM + /LVSI + (LNM) samples from a cohort, were subjected to DIA to identify differentially expressed proteins (DEPs) for LVSI and LNM. Subsequently, Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were performed for DEP functional annotation. Protein–protein interaction (PPI) and weighted gene coexpression network analysis (WGCNA) were used to detect new effective plasma biomarkers and possible mechanisms. RESULTS: A total of 79 DEPs were identified in the cohort. GO and KEGG analyses showed that DEPs were mainly enriched in the complement and coagulation pathway, lipid and atherosclerosis pathway, HIF-1 signal transduction pathway and phagosome and autophagy. WGCNA showed that the enrichment of the green module differed greatly between groups. Six interesting core DEPs (SPARC, HPX, VCAM1, TFRC, ERN1 and APMAP) were confirmed to be potential plasma diagnostic markers for LVSI and LNM in cervical cancer patients. CONCLUSION: Proteomic signatures developed in this study reflected the potential plasma diagnostic markers and new possible pathogenesis mechanisms in the LVSI and LNM of cervical cancer. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12014-023-09427-8. BioMed Central 2023-09-09 /pmc/articles/PMC10492398/ /pubmed/37689639 http://dx.doi.org/10.1186/s12014-023-09427-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Han, Sai
Liu, Xiaoli
Ju, Shuang
Mu, Wendi
Abulikemu, Gulijinaiti
Zhen, Qianwei
Yang, Jiaqi
Zhang, Jingjing
Li, Yi
Liu, Hongli
Chen, Qian
Cui, Baoxia
Wu, Shuxia
Zhang, Youzhong
New mechanisms and biomarkers of lymph node metastasis in cervical cancer: reflections from plasma proteomics
title New mechanisms and biomarkers of lymph node metastasis in cervical cancer: reflections from plasma proteomics
title_full New mechanisms and biomarkers of lymph node metastasis in cervical cancer: reflections from plasma proteomics
title_fullStr New mechanisms and biomarkers of lymph node metastasis in cervical cancer: reflections from plasma proteomics
title_full_unstemmed New mechanisms and biomarkers of lymph node metastasis in cervical cancer: reflections from plasma proteomics
title_short New mechanisms and biomarkers of lymph node metastasis in cervical cancer: reflections from plasma proteomics
title_sort new mechanisms and biomarkers of lymph node metastasis in cervical cancer: reflections from plasma proteomics
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10492398/
https://www.ncbi.nlm.nih.gov/pubmed/37689639
http://dx.doi.org/10.1186/s12014-023-09427-8
work_keys_str_mv AT hansai newmechanismsandbiomarkersoflymphnodemetastasisincervicalcancerreflectionsfromplasmaproteomics
AT liuxiaoli newmechanismsandbiomarkersoflymphnodemetastasisincervicalcancerreflectionsfromplasmaproteomics
AT jushuang newmechanismsandbiomarkersoflymphnodemetastasisincervicalcancerreflectionsfromplasmaproteomics
AT muwendi newmechanismsandbiomarkersoflymphnodemetastasisincervicalcancerreflectionsfromplasmaproteomics
AT abulikemugulijinaiti newmechanismsandbiomarkersoflymphnodemetastasisincervicalcancerreflectionsfromplasmaproteomics
AT zhenqianwei newmechanismsandbiomarkersoflymphnodemetastasisincervicalcancerreflectionsfromplasmaproteomics
AT yangjiaqi newmechanismsandbiomarkersoflymphnodemetastasisincervicalcancerreflectionsfromplasmaproteomics
AT zhangjingjing newmechanismsandbiomarkersoflymphnodemetastasisincervicalcancerreflectionsfromplasmaproteomics
AT liyi newmechanismsandbiomarkersoflymphnodemetastasisincervicalcancerreflectionsfromplasmaproteomics
AT liuhongli newmechanismsandbiomarkersoflymphnodemetastasisincervicalcancerreflectionsfromplasmaproteomics
AT chenqian newmechanismsandbiomarkersoflymphnodemetastasisincervicalcancerreflectionsfromplasmaproteomics
AT cuibaoxia newmechanismsandbiomarkersoflymphnodemetastasisincervicalcancerreflectionsfromplasmaproteomics
AT wushuxia newmechanismsandbiomarkersoflymphnodemetastasisincervicalcancerreflectionsfromplasmaproteomics
AT zhangyouzhong newmechanismsandbiomarkersoflymphnodemetastasisincervicalcancerreflectionsfromplasmaproteomics